Erratum: Phosphorylation of Akt/GSK-3ß/eNOS amplifies 5-HT 2B receptor blockade mediated anti-hypertrophic effect in rats (FEBS Letters (2012), 586 (180-185) DOI: 10.1016/j.febslet.2011.12.015);Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats

FEBS Letters

Volumn 586, Issue 2, 2012, Pages 180-185

  Bharti, Saurabh ^a   Singh, Ratnakar ^a   Chauhan, S S ^a   Hussain, Tajamul ^b   Al Attas, Omar S ^b   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Akt GSK 3 ; Cardiac hypertrophy; Isoproterenol; SB 204741; SB 216763

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 METHYL 5 ISOTHIAZOLYL)UREA; 2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPRENALINE; PROTEIN BAX; PROTEIN KINASE B; SEROTONIN 2 ANTAGONIST; SEROTONIN 2B RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTROPHIC EFFECT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; INFLAMMATION; MALE; MOLECULAR INTERACTION; MYOCARDIAL DISEASE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR BLOCKING; TREATMENT DURATION;

RATTUS;

EID: 84855778716     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.05.032     Document Type: Erratum

References (22)

1. M. Juhaszova Role of glycogen synthase kinase-3beta in cardioprotection Circ. Res. 104 2009 1240 1252
2. A.G. Ramage, and C.M. Villalón 5-Hydroxytryptamine and cardiovascular regulation Trends Pharmacol. Sci. 29 2008 472 481
3. L. Monassier Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice Hypertension 52 2008 301 307
4. C.F. Bai Role of 5-HT2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats Clin. Exp. Pharmacol. Physiol. 37 2010 e145 e151
5. F.N. Obame Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2, 4-dichlorophenyl)-4(1-methyl-1H-indol-3- yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore J. Pharmacol. Exp. Ther. 326 2008 252 258 (Pubitemid 351872117)
6. S.N. Goyal, S. Bharti, J. Bhatia, T.C. Nag, R. Ray, and D.S. Arya Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischemic-reperfusion injury in experimental diabetes Diabetes Obes. Metab. 13 2011 533 541
7. H. Ohkawa, N. Ohishi, and K. Yagi Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358 (Pubitemid 9194347)
8. R.A. Lawrence, and R.F. Burk Glutathione peroxidase activity in selenium-deficient rat liver Biochem. Biophys. Res. Commun. 71 1976 952 958
9. P.H. Sugden Ras, Akt, and mechanotransduction in the cardiac myocyte Circ. Res. 93 2003 1179 1192 (Pubitemid 37543058)
10. A. Michael Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart J. Biol. Chem. 279 2004 21383 21393 (Pubitemid 38656547)
11. P. Zhai, and J. Sadoshima Overcoming an energy crisis?: an adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion Circ. Res. 103 2008 910 913
12. X. Chen The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy Mol. Cell. Biol. 26 2006 4462 4473 (Pubitemid 43877567)
13. A. Baurand Beta-catenin downregulation is required for adaptive cardiac remodeling Circ. Res. 100 2007 1353 1362 (Pubitemid 46742926)
14. M.P. Flaherty ENOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression Cardiovasc. Toxicol. 7 2007 165 177 (Pubitemid 47575002)
15. D. Catalucci Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability J. Cell Biol. 184 2009 923 933
16. O. Basset Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes Biochem. J. 395 2006 267 276
17. S. Kaga, L. Zhan, E. Altaf, and N. Maulik Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium J. Mol. Cell. Cardiol. 40 2006 138 147 (Pubitemid 43012125)
18. G.W. Dorn 2nd Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodeling Cardiovasc. Res. 81 2009 465 473
19. G. Hall, J.D. Hasday, and T.B. Rogers Regulating the regulator: NF-kappaB signaling in heart J. Mol. Cell. Cardiol. 41 2006 580 591 (Pubitemid 44374539)
20. J. Kuroda NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. USA 107 2010 15565 15570
21. Y. Kuwabara Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes Circ. J. 71 2007 1047 1051 (Pubitemid 46998018)
22. Y.J. Liang Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes Cardiovasc. Res. 72 2006 303 312